Tag: IntriCon



IntriCon Provides Insights into OTC Hearing Aid Market; Experiences Some Headwinds in Q2 2019

The company is bullish on the prospects of the upcoming OTC hearing device regulations from FDA, which it anticipates being issued this November and implemented in mid-2020. In his comments to investors, IntriCon CEO Mark Gorder was also optimistic that the new OTC hearing device regulations would be more liberal relative to the amount of allowable gain and for whom the devices might be intended.

ADA and IntriCon Partner to Launch earVenture Low-Cost Hearing Aids

ADA has partnered with IntriCon to launch a low-cost hearing aid to compete with PSAPs, over-the-counter, and Big Box hearing devices. With a wholesale membership cost ranging from $150-250, the new hearing aids are expected to present a high-quality low-cost alternative that will place the provider and evidence-based services—not the device—at the center of the hearing healthcare journey.

Read More